Víctor Manuel Martínez-Taboada

Impact of the 2023 ACR/EULAR classification criteria on thrombotic antiphospholipid syndrome: reclassification patterns and long-term outcomes in a 419-patient cohort

The 2023 ACR/EULAR classification criteria for antiphospholipid syndrome (APS) were developed to improve specificity and to define more homogeneous research populations. However, their performance in real-world cohorts of thrombotic APS with long-term hard outcomes remains insuff...

Organ damage progression in antiphospholipid antibody carriers: a longitudinal cohort study

Abstract Background The DIAPS scale is a useful tool for quantifying organ damage in antiphospholipid syndrome (APS). However, little is known about the kinetics of organ damage in antiphospholipid antibody (aPL) carriers. This study aimed to characterize damage progression in aP...